Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis

被引：0
|
作者：
Silverberg, J. I. [1 ]
Barbarot, S. [2 ]
Gooderham, M. [3 ]
Simon, J. C. [4 ]
Simpson, E. [5 ]
Kurbasic, A. [6 ]
Olsen, C. K. [6 ]
Cork, M. J. [7 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA
[2] CHU Nantes, Dept Dermatol, Nantes, France
[3] SKiN Ctr Dermatol, Peterborough, ON, Canada
[4] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Leipzig, Germany
[5] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[6] LEO Pharma AS, Ballerup, Denmark
[7] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
342
引用
收藏
页码：E64 / E65
页数：2
相关论文
共 50 条
  • [21] Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial
    Angela Michelotti
    Enza Cestone
    Ileana De Ponti
    Silvana Giardina
    Marta Pisati
    Eleonora Spartà
    Francesco Tursi
    European Journal of Dermatology, 2021, 31 : 225 - 232
  • [22] Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial
    Silverberg, J. I.
    Toth, D.
    Bieber, T.
    Alexis, A. F.
    Elewski, B. E.
    Pink, A. E.
    Hijnen, D.
    Jensen, T. N.
    Bang, B.
    Olsen, C. K.
    Kurbasic, A.
    Weidinger, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : 450 - 463
  • [23] Safety of anti-IL-13 Treatment with Tralokinumab in Adult Patients with moderate to severe Atopic Dermatitis: A Pooled Analysis of five Randomized, Double-Blind, Placebo Controlled Phase II and III Studies
    Wollenberg, A.
    Merola, J. F.
    Silverberg, J., I
    Zachariae, R.
    Olsen, C. K.
    Simpson, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 62 - 63
  • [24] Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
    Saeki, H.
    Kabashima, K.
    Tokura, Y.
    Murata, Y.
    Shiraishi, A.
    Tamamura, R.
    Randazzo, B.
    Imanaka, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 419 - 427
  • [25] Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studies
    Clot, Pierre-Francois
    Kamal, Mohamed
    Sun, Jing
    Xu, Christine
    Kong, Fangyuan
    Gu, Yongzhen
    Yang, Na
    Yin, WeiHong
    Chen, Bing
    Ming, Jeffrey E.
    Yuan, Yaozong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [26] Polypodium leucotomos Extract in Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
    Ramirez-Bosca, A.
    Zapater, P.
    Betlloch, I.
    Albero, F.
    Martinez, A.
    Diaz-Alperi, J.
    Horga, J. F.
    ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 (07): : 599 - 607
  • [27] Efficacy of Probiotics in Children and Adolescents With Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Study
    Andrade, Paula Danielle Santa Maria Albuquerque de
    Silva, Jorgete
    Carregaro, Vanessa
    Sacramento, Lais Amorim
    Roberti, Luciana Rodrigues
    Aragon, Davi Casale
    Carmona, Fabio
    Roxo-Junior, Persio
    FRONTIERS IN NUTRITION, 2022, 8
  • [28] Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial
    Yang, Hyeon-Jong
    Min, Taek Ki
    Lee, Hae Won
    Pyun, Bok Yang
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2014, 6 (03) : 208 - 215
  • [29] THE SAFETY AND TOLERABILITY OF LACOSAMIDE IN RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II/III CLINICAL TRIALS
    Gil-Nagel, A.
    Biton, V.
    Fountain, N.
    Rosenow, F.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 110 - 110
  • [30] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
12345